Cargando…
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
BACKGROUND: Income-related inequality measures such as the concentration index are often used to describe the unequal distribution of health, health care access, or expenditure in a single measure. This study demonstrates the use of such measures to evaluate the distributional impact of changes in h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469203/ https://www.ncbi.nlm.nih.gov/pubmed/30992000 http://dx.doi.org/10.1186/s12939-019-0955-9 |
_version_ | 1783411599575351296 |
---|---|
author | Carvalho, Natalie Petrie, Dennis Chen, Linkun Salomon, Joshua A. Clarke, Philip |
author_facet | Carvalho, Natalie Petrie, Dennis Chen, Linkun Salomon, Joshua A. Clarke, Philip |
author_sort | Carvalho, Natalie |
collection | PubMed |
description | BACKGROUND: Income-related inequality measures such as the concentration index are often used to describe the unequal distribution of health, health care access, or expenditure in a single measure. This study demonstrates the use of such measures to evaluate the distributional impact of changes in health insurance coverage. We use the example of Medicare Part D in the United States, which increased access to prescription medications for Medicare beneficiaries from 2006. METHODS: Using pooled cross-sectional samples from the Medical Expenditure Panel Survey for 1997–2011, we estimated income-related inequality in drug expenditures over time using the concentration and generalised concentration indices. A difference-in-differences analysis investigated the change in inequality in drug expenditures, as measured using the concentration index and generalised concentration index, between the elderly (over 65 years) and near-elderly (54–63 years) pre- and post-implementation of Medicare Part D. RESULTS: Medicare Part D increased public drug expenditure while out-of-pocket and private spending fell. Public drug expenditures favoured the poor during all study periods, but the degree of pro-poorness declined in the years immediately following the implementation of Part D, with the poor gaining less than the rich in both relative and absolute terms. Part D also appeared to result in a fall in the pro-richness of private insurance drug expenditure in absolute terms but have minimal distributional impact on out-of-pocket expenditure. These effects appeared to be short lived, with a return to the prevailing trends in both concentration and generalised concentration indices several years following the start of Part D. CONCLUSIONS: The implementation of Medicare Part D significantly reduced the degree of pro-poorness in public drug expenditure. The poor gained less of the increased public drug expenditure than the rich in both relative and absolute terms. This study demonstrates how income-related inequality measures can be used to estimate the impact of health system changes on inequalities in health expenditure and provides a guide for future evaluations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12939-019-0955-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6469203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64692032019-04-23 The impact of Medicare part D on income-related inequality in pharmaceutical expenditure Carvalho, Natalie Petrie, Dennis Chen, Linkun Salomon, Joshua A. Clarke, Philip Int J Equity Health Research BACKGROUND: Income-related inequality measures such as the concentration index are often used to describe the unequal distribution of health, health care access, or expenditure in a single measure. This study demonstrates the use of such measures to evaluate the distributional impact of changes in health insurance coverage. We use the example of Medicare Part D in the United States, which increased access to prescription medications for Medicare beneficiaries from 2006. METHODS: Using pooled cross-sectional samples from the Medical Expenditure Panel Survey for 1997–2011, we estimated income-related inequality in drug expenditures over time using the concentration and generalised concentration indices. A difference-in-differences analysis investigated the change in inequality in drug expenditures, as measured using the concentration index and generalised concentration index, between the elderly (over 65 years) and near-elderly (54–63 years) pre- and post-implementation of Medicare Part D. RESULTS: Medicare Part D increased public drug expenditure while out-of-pocket and private spending fell. Public drug expenditures favoured the poor during all study periods, but the degree of pro-poorness declined in the years immediately following the implementation of Part D, with the poor gaining less than the rich in both relative and absolute terms. Part D also appeared to result in a fall in the pro-richness of private insurance drug expenditure in absolute terms but have minimal distributional impact on out-of-pocket expenditure. These effects appeared to be short lived, with a return to the prevailing trends in both concentration and generalised concentration indices several years following the start of Part D. CONCLUSIONS: The implementation of Medicare Part D significantly reduced the degree of pro-poorness in public drug expenditure. The poor gained less of the increased public drug expenditure than the rich in both relative and absolute terms. This study demonstrates how income-related inequality measures can be used to estimate the impact of health system changes on inequalities in health expenditure and provides a guide for future evaluations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12939-019-0955-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-16 /pmc/articles/PMC6469203/ /pubmed/30992000 http://dx.doi.org/10.1186/s12939-019-0955-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Carvalho, Natalie Petrie, Dennis Chen, Linkun Salomon, Joshua A. Clarke, Philip The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title_full | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title_fullStr | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title_full_unstemmed | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title_short | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure |
title_sort | impact of medicare part d on income-related inequality in pharmaceutical expenditure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469203/ https://www.ncbi.nlm.nih.gov/pubmed/30992000 http://dx.doi.org/10.1186/s12939-019-0955-9 |
work_keys_str_mv | AT carvalhonatalie theimpactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT petriedennis theimpactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT chenlinkun theimpactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT salomonjoshuaa theimpactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT clarkephilip theimpactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT carvalhonatalie impactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT petriedennis impactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT chenlinkun impactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT salomonjoshuaa impactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure AT clarkephilip impactofmedicarepartdonincomerelatedinequalityinpharmaceuticalexpenditure |